Fidelity Investments’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,853
| Closed | -$28.3K | – | 5305 |
|
|
2024
Q4 | $28.3K | Sell |
47,853
-1,649
| -3% | -$975 | ﹤0.01% | 4087 |
|
|
2024
Q3 | $87.1K | Sell |
49,502
-2,141
| -4% | -$3.77K | ﹤0.01% | 3531 |
|
|
2024
Q2 | $70.8K | Buy |
51,643
+48,270
| +1,431% | +$66.1K | ﹤0.01% | 3443 |
|
|
2024
Q1 | $11.6K | Buy |
3,373
+286
| +9% | +$984 | ﹤0.01% | 4216 |
|
|
2023
Q4 | $7.59K | Buy |
3,087
+237
| +8% | +$583 | ﹤0.01% | 4319 |
|
|
2023
Q3 | $4.85K | Buy |
2,850
+981
| +52% | +$1.67K | ﹤0.01% | 4336 |
|
|
2023
Q2 | $5.61K | Sell |
1,869
-2,097
| -53% | -$6.29K | ﹤0.01% | 4331 |
|
|
2023
Q1 | $10.6K | Buy |
3,966
+2,598
| +190% | +$6.96K | ﹤0.01% | 4104 |
|
|
2022
Q4 | $11.3K | Sell |
1,368
-17,638
| -93% | -$145K | ﹤0.01% | 3969 |
|
|
2022
Q3 | $146K | Sell |
19,006
-295,856
| -94% | -$2.27M | ﹤0.01% | 3147 |
|
|
2022
Q2 | $897K | Sell |
314,862
-2,604,601
| -89% | -$7.42M | ﹤0.01% | 2702 |
|
|
2022
Q1 | $14.6M | Sell |
2,919,463
-1,001,209
| -26% | -$5.01M | ﹤0.01% | 1944 |
|
|
2021
Q4 | $77M | Sell |
3,920,672
-883,731
| -18% | -$17.3M | 0.01% | 1229 |
|
|
2021
Q3 | $141M | Buy |
4,804,403
+57,454
| +1% | +$1.69M | 0.01% | 958 |
|
|
2021
Q2 | $201M | Buy |
4,746,949
+669,358
| +16% | +$28.4M | 0.02% | 829 |
|
|
2021
Q1 | $207M | Buy |
4,077,591
+2,297,505
| +129% | +$117M | 0.02% | 774 |
|
|
2020
Q4 | $60.5M | Buy |
+1,780,086
| New | +$60.5M | 0.01% | 1246 |
|